A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models
前列腺素 E(2) EP(4) 受体的新型拮抗剂可抑制 Th1 分化和 Th17 扩增，并且在关节炎模型中具有口服活性
期刊:British Journal of Pharmacology
影响因子:6.8
doi:10.1111/j.1476-5381.2010.00647.x
Q Chen, K Muramoto, N Masaaki, Y Ding, H Yang, M Mackey, W Li, Y Inoue, K Ackermann, H Shirota, I Matsumoto, M Spyvee, S Schiller, T Sumida, F Gusovsky, M Lamphier
